Role of Extracellular Calcium in Contractions Produced by Activation of Postsynaptic Alpha-2 Adrenoceptors in the Canine Saphenous Vein
Overview
Authors
Affiliations
Canine saphenous vein (CSV) has been shown to contain both postsynaptic alpha-1 and alpha-2 adrenoceptors. Our previous studies have shown that activation of postsynaptic alpha-1 adrenoceptors in this tissue utilizes both extracellular and intracellular Ca++ to produce contractions. In the present study, the source of calcium mobilized by activation of postsynaptic alpha-2 adrenoceptors in CSV was elucidated. Contractions of tissue rings to the supramaximal concentrations of three selective alpha-2 agonists, B-HT 920, M-7 and clonidine, were determined in the absence and presence of 5 mM La . In the presence of La , clonidine and M-7 produced small but statistically significant contractions (8-14% of control) which were abolished when the alpha-1 adrenoceptors were inactivated by phenoxybenzamine (10(-7) M, 30 min). In contrast, contractions to B-HT 920 were abolished completely in the presence of La . All the three alpha-2 agonists stimulated 45Ca++ uptake into CSV (0.3-0.4 mmol/kg wet weight, 10 min). 45Ca++ efflux studies demonstrated that the selective alpha-2 agonist, B-HT 920 (10(-5) M plus 10(-7) M phenoxybenzamine), did not induce an increase in the rate of 45Ca++ efflux. In contrast, an augmented 45Ca++ efflux rate was observed with the alpha-1 agonist, phenylephrine (10(-4) M plus 10(-7) M rauwolscine). These results suggest that activation of postsynaptic alpha-2 adrenoceptors in CSV utilizes primarily extracellular Ca++ to produce contractions.
Hadadianpour E, Pouramiri B Mol Divers. 2019; 24(1):241-252.
PMID: 30953294 DOI: 10.1007/s11030-019-09945-4.
Bova S, Trevisi L, Debetto P, Cima L, Furnari M, Luciani S Br J Pharmacol. 1996; 117(6):1041-6.
PMID: 8882594 PMC: 1909795. DOI: 10.1111/j.1476-5381.1996.tb16694.x.
The mechanism of action of alpha 2-adrenoceptors in human isolated subcutaneous resistance arteries.
Parkinson N, Hughes A Br J Pharmacol. 1995; 115(8):1463-8.
PMID: 8564206 PMC: 1908876. DOI: 10.1111/j.1476-5381.1995.tb16638.x.
Aleixandre M, Puerro M, Pintado A Naunyn Schmiedebergs Arch Pharmacol. 1995; 351(5):500-6.
PMID: 7643913 DOI: 10.1007/BF00171041.
Glusa E, Markwardt F Naunyn Schmiedebergs Arch Pharmacol. 1987; 335(5):529-33.
PMID: 3614388 DOI: 10.1007/BF00169119.